Recent Blog Posts

View Post: World Pharma News - Merck Receives CHMP Positive Opinion for New ...
22 Nov 2009
... alfa injection) as a treatment in controlled ovarian stimulation (COS) in combination with a GnRH antagonist for the development of multiple follicles in women participating in an assisted reproductive technology (ART) program. ...
View Blog: World Pharma News - http://www.worldpharmanews.com/

---

View Post: Infertility drug corifollitropin alfa (Elonva) single dose ...
20 Nov 2009 by pillscribe  
Corifollitropin alfa injection (Elonva) is helpful as a treatment in controlled ovarian stimulation (COS) in combination with a GnRH antagonist for the development of multiple follicles in women participating in an assisted reproductive ...
View Blog: DWS Pill Scribe - http://www.dancewithshadows.com/pillscribe/

---

View Post: Fertility and Infertility Research News Portal » Lupron Therapy ...
16 Nov 2009 by admin  
Either the long Lupron approach or the agonist/antagonist conversion protocol (A/ACP) is used. With the A/ACP, Lupron is supplanted by low dosage antagonist therapy. In both cases, daily Gonadotropin (FSH and LH) injections are ...
View Blog: Fertility and Infertility Research News Portal - http://fertilityportal.com/

---

View Post: Merck Receives CHMP Positive Opinion for New Fertility Treatment ...
20 Nov 2009
First in the Class of Sustained Follicle Stimulants Would Reduce the Number of Treatment Injections for Patients. ... Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has recommended approval of ELONVA® (corifollitropin alfa injection) as a treatment in controlled ovarian stimulation (COS) in combination with a GnRH antagonist for the development of multiple follicles in women participating in an assisted reproductive technology (ART) program. ...
View Blog: Latest articles from PMD - http://www.pmdcentral.com/

---

View Post: INTRAHYPOTHALAMIC INJECTION OF THE HIV-1 ENVELOPE GLYCOPROTEIN ...
11 Nov 2009 by Benamar, K., addou, S., Yondorf, M., Geller,...  
To demonstrate the possible links between the gp120 and CXCR4 in generating the fever, we pretreated the rats with 1,1'-[1,4-phenylenebis(methylene)]bis[1,4,8,11-tetraazacyclotetradecane (AMD 3100), an antagonist of SDF-1/CXCL12, ...
View Blog: JPET Fast Forward - http://jpet.aspetjournals.org/

---

View Post: antagon injection (r)
7 Dec 2007 by Info  
brand name: antagon injection® active ingredient: ganirelix acetate. strength(s): 250 mcg/0.5 ml. dosage form(s): injection company name: organon, inc. availability: prescription only *date approved by the fda: july 29, 1999 ...
View Blog: FDA Approved - http://fdaapproved.blogspot.com/

---

View Post: Alkermes Announces Positive Results from Phase 3 Clinical Study of ...
16 Nov 2009
XR-NTX, marketed by Alkermes as VIVITROL®, is an opioid antagonist administered once-monthly by intramuscular injection and is approved in the U.S. for the treatment of alcohol dependence. If approved by the FDA for the treatment of ...
View Blog: Drugs.com - Clinical Trials - http://www.drugs.com/clinical_trials.html

---

View Post: BOTOX ST LOUIS - KANSAS CITY MISSOURI - ILLINOIS DR MICHELE KOO ...
28 May 2009 by drmichelekoo  
... enhancing the effect of the antagonist lateral frontalis muscle. This method can be employed when injecting for crow's feet with extension of the lateral canthal area injections (2.5 units/0.1 ml) into the lateral sub-brow region. ...
View Blog: Plastic Surgeon Dr. Michele Koo's Blog... - http://www.drmichelekoo.com/blog/

---

View Post: Ganirelix Acetate Injection (Ganirelix) Drug Information: Uses ...
1 Aug 2008
An initial release of endogenous gonadotropins has not been detected with Ganirelix Acetate, which is consistent with an antagonist effect. Upon discontinuation of Ganirelix Acetate, pituitary LH and FSH levels are fully recovered ...
View Blog: RxList - News and Features - http://www.rxlist.com/script/main/hp.asp

---

View Post: What's New from the Office of Oncology Drug Products*
FDA ...
6 Nov 2009 ...
View Blog: http://www.healthcare-packaging.com/

---